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Sumário 
 
A engenharia de tecidos constitui uma elevada promessa para a completa restauração de tecidos 
e de órgãos danificados, podendo assim mudar o paradigma da medicina atual. Sendo a base da medicina 
regenerativa, possui o intuito de revolucionar as formas de melhorar a saúde e a qualidade de vida de 
milhões de pessoas em todo o mundo, restaurando, mantendo ou melhorando a função dos tecidos e 
órgãos. Devido ao seu elevado potencial, são já numerosos os exemplos de aplicações publicados, quer 
em revistas científicas quer nos meios de comunicação normais. De realçar que esta é uma área 
multidisciplinar com vertentes sociais, económicas, ambientais e éticas, necessitando, portanto, de 
equipas de profissionais interdisciplinares como da medicina, biologia, química, física, ciências dos 
materiais, computacionais e de engenharias.  
Nas últimas décadas, a engenharia de tecidos tem-se debruçado sobre o desenvolvimento de 
substitutos capazes de simular histológica, fisiológica e morfologicamente o tecido humano. Esta 
necessidade surgiu devido à procura de suportes eficazes e seguros para reparação e regeneração de 
vários tecidos e órgãos vitais; assim como a carência de modelos adequados dos sistemas do corpo 
humano. Os modelos animais tradicionalmente utilizados para suprimir esta última necessidade não 
permitem mimetizar com precisão as principais características das patologias humanas, em grande parte 
devido às diferenças entre as espécies. Em adição, não é possível a aplicação deste tipo de modelos em 
plataformas de “high-throughput”, que permitem testar, em paralelo e com rapidez, centenas a milhares 
de compostos para identificação e seleção dos mais promissores, reduzindo os custos e duração dos 
ensaios clínicos. Desta forma, o desenvolvimento de novos modelos celulares que mimetizem o tecido 
humano e patologias associadas de forma mais precisa tem ganho elevado interesse. 
Tendo como objetivo mimetizar in vitro as características de tecidos humanos, é fundamental 
ter em conta a organização celular tridimensional (3D) do tecido. Esta configuração 3D deverá permitir 
a regulação de parâmetros como a disponibilidade de nutrientes ou fatores de crescimento, o stress 
mecânico induzido pelo sistema de cultura, as interações célula-célula e célula-matriz extracelular, entre 
outros; pois terá um impacto direto na ativação e direcionamento das vias de diferenciação e 
funcionalidade celular, conferindo uma maior similaridade entre o modelo e o tecido in vivo. Com este 
propósito, têm sido desenvolvidos sistemas com um maior nível de complexidade, em comparação com 
as tradicionais culturas em monocamada de células. Entre os sistemas mais utilizados encontram-se as 
culturas in vitro 3D, em que a estratégia passa pela encapsulação das células em matrizes. Estes modelos 
3D poderão assim atingir, a longo prazo, a substituição da técnica tradicional de transplantação de órgãos 
e tecidos, permitir a diminuição da dependência sobre a utilização de modelos animais, e contribuir 
fortemente para o desenvolvimento de ensaios mais precisos para a avaliação e identificação de novos 
fármacos, apresentando-se, desta forma, como uma alternativa complementar tanto para a investigação 
como para a indústria. No entanto, um dos maiores desafios em engenharia de tecidos é a vascularização 
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e a inervação de tecidos, que permitam o real funcionamento a médio e longo prazo dos tecidos/ órgãos. 
Para tal, é necessário compreender os desafios relacionados, por exemplo, com a fabricação de uma rede 
tridimensional funcional de tecidos que permita uma perfusão e difusão adequada para uma boa 
disponibilização de nutrientes e de oxigénio, para o normal crescimento, diferenciação e proliferação 
celular. É assim crucial o desenvolvimento de modelos/microambientes 3D envolvendo células, e/ou 
fatores de crescimento, e que simulem e permitam o teste de biomateriais quanto às suas características 
vasculares mecânicas, endoteliais e anti-trombogénicas. Para abordar este desafio, o objetivo desta tese 
foi melhorar as características de um material, que envolvia a conjugação de fibrina com heparina (HCF) 
e a inclusão de microcanais num hidrogel para aplicações neurais e vasculares. A melhoria de hidrogéis 
pré-existentes e a adição de microcanais podem promover suportes adequados para engenharias de 
tecido neural e vascular. 
Os hidrogéis são polímeros que através de ligações cruzadas formam uma rede tridimensional 
hidrofílica de cadeias poliméricas e que absorvem uma quantidade considerável de solvente, devido à 
sua forte afinidade com a água e com a maioria das soluções aquosas. São considerados materiais 
fortemente hidratados e são aplicados na regeneração de tecidos como substitutos da matriz extracelular. 
A sua importância deve-se à semelhança das suas propriedades físicas com as dos tecidos in vivo, tais 
como o elevado conteúdo em água, consistência macia e elástica, e baixa tensão superficial. A fibrina 
foi o material selecionado de forma a constituir a estrutura suporte do modelo 3D devido à possibilidade 
de se ajustar a morfologia, propriedades mecânicas e estabilidade do hidrogel controlando a sua 
concentração. Para além disso, a fibrina é biocompatível, a sua taxa de degradação é controlável e os 
produtos de degradação não são tóxicos. Quanto à escolha da funcionalização do hidrogel com heparina 
(HCF, Heparin-conjugated fibrinogen), esta foi devido à elevada afinidade da heparina por fatores de 
crescimento como o fator de crescimento vascular endotelial (VEGF) e o fator de crescimento neural 
(NGF). A retenção destes fatores pode promover um ambiente ideal para a adesão, migração, orientação 
e proliferação de células. Para efetuar o estudo do comportamento de células no hidrogel, foram 
incorporados tenócitos, fibroblastos alongados e especializados do tendão. A sua importância deve-se 
aos fibroblastos serem células que residem dentro da matriz extracelular de vários tecidos conjuntivos, 
e que são críticos para a síntese e reparação da matriz. Em resposta a lesões e durante o crescimento 
tumoral, os fibroblastos são ativados e reconhecidos como miofibroblastos, células de cicatrização de 
feridas que reparam o tecido danificado através da secreção de colagénio, fibronectina, proteoglicanos, 
fatores de crescimento do tecido conjuntivo, entre outras proteínas e enzimas. Como sintetizadores e 
modificadores da matriz extracelular, os fibroblastos também desempenham um papel fundamental no 
crescimento nervoso e na angiogénese. A angiogénese é a formação de novos vasos sanguíneos a partir 
de vasculatura existente. O processo ocorre em condições fisiológicas, como por exemplo, durante o 
desenvolvimento embrionário e cicatrização de feridas; e em condições patológicas, como por exemplo, 
durante o crescimento tumoral. O processo envolve a ligação de fatores de crescimento como o VEGF, 
importantes para a proliferação, migração e diferenciação de células, promovendo a formação de novos 
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vasos sanguíneos. O electrospinning foi o método escolhido para a fabricação das microfibras, uma vez 
que este processo permite obter razões elevadas de área superficial por volume, dimensão de poros 
adequados às dimensões das células, funcionalização de superfícies e múltiplos locais para interação e 
conexão celular, e reduzida limitação de fenómenos de transferência de massa. As microfibras foram 
baseadas em poly(N-isopropylacrylamide) (pNIPAM), um polímero termorresistente, mas que apresenta 
uma temperatura de solução crítica (LCST) de 32°C. Esta característica permite a incorporação das 
microfibras no HCF e a sua subsequente remoção, originando micro-canalizações. Neste âmbito, é 
fabricado um hidrogel otimizado com microcanais, o qual pode constituir um modelo biomimético 
funcional e viável para a promoção de vascularização e de inervação de tecidos. Para alcançar este 
objetivo, o presente trabalho englobou: (1) o processo de design, fabricação e caracterização do hidrogel, 
(2) seeding do hidrogel com tenócitos para testar comportamentos celulares e (3) fabricação de 
microfibras pNIPAM para criação dos microcanais no hidrogel.  
Das experiências realizadas observou-se que foi possível ativar e ligar a heparina ao 
fibrinogénio. Também foi observado que o tempo de gelificação dos hidrogéis aumenta com o aumento 
da concentração de fibrina conjugada com heparina. Observaram-se dificuldades de polimerização 
aquando da utilização de 40%, 50%, 75% e 100% de concentração de HCF. Através de análises com o 
corante azul de dimetilmetileno e de ensaios de imunoabsorção enzimática (ELISA), quantificou-se a 
heparina e o fator de crescimento VEGF-A dentro do gel e da sua libertação entre 5 e 7 dias, 
respetivamente. Observou-se que os hidrogéis conseguem reter quer heparina quer VEGF-A. Nos 
estudos 2D e 3D de incorporação de tenócitos nos hidrogéis de HCF, observou-se a adesão das células 
em hidrogéis com concentrações de 10%, 35% e 50% de HCF. As melhores configurações de diâmetro 
e de alinhamento de fibras foram obtidas por electrospinning com fibras de 50% pNIPAM em 
clorofórmio/DMF numa razão de 7:3, bem como de 40% pNIPAM em clorofórmio/DMF numa razão 
de 3:1. Em termos de perspetivas futuras, sugere-se a continuação da otimização do processo de 
formação dos hidrogéis de HCF de forma a minimizar as dificuldades de polimerização observadas. 
Também se sugere uma melhor caracterização dos hidrogéis, especialmente em situações de 
incorporação de células. Em suma, espera-se que os resultados obtidos no presente trabalho contribuam 
para o desenvolvimento de modelos biomiméticos neuronais e vasculares, singulares ou combinados, 
para estudos in vitro e aplicações regenerativas. 
 
Palavras-chave:   
Engenharia de tecidos, fibrina, heparina, hidrogel, electrospinning.  
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Abstract 
 
One of the greatest challenges encountered in Tissue Engineering (TE) has been the 
vascularization and innervation of tissues, which allow the medium to long-term functioning of the 
tissues/ organs. To address this challenge, the goal of this thesis was to optimize the characteristics of a 
material, involving the conjugation of heparin to fibrin and inclusion of pNIPAM micro-channels in a 
hydrogel for neural and vascular applications. Improvement of pre-existing hydrogels and the addition 
of microchannels may promote suitable supports for neural and vascular TE. 
Experiments towards the optimization and characterization of heparin-conjugated fibrin (HCF) 
hydrogels (with gelation kinetics study, alcian blue staining, heparin quantification and VEGF-A release 
profile), tenocytes seeding to test cell behavior, and fabrication of pNIPAM microfibers for hydrogel 
microchanneling were conducted. It was observed that it was possible to activate and bind heparin to 
fibrinogen. It was also observed that the gelation time of the hydrogels increases with increasing 
concentration of fibrin conjugated with heparin. Polymerization difficulties were observed when using 
40%, 50%, 75% and 100% HCF concentration. Through dimethylmethylene blue dye and enzyme-
linked immunosorbent assay (ELISA) assays, heparin and VEGF-A growth factor were quantified 
within the gel and delivered in 5-7 days. It was observed that the hydrogels can retain either heparin or 
VEGF-A. In the 2D and 3D studies of tenocyte incorporation in HCF hydrogels, cell adhesion was 
observed in hydrogels at concentrations of 10%, 35% and 50% of HCF. The best diameter and fiber 
alignment configurations were obtained by electrospinning with 50% pNIPAM fibers in chloroform/ 
DMF in a ratio of 7:3, as well as 40% pNIPAM in chloroform/ DMF in a ratio of 3:1. 
In terms of future perspectives, it is suggested a continued optimization of the HCF hydrogels' 
formation process in order to improve the acquisition of a consistent HCF product in larger amounts, 
consequently avoiding the need of constant batch preparation and delay of important and further 
investigation assays. It is also suggested further characterization of the hydrogels, especially in situations 
of cells incorporation, to determine with certainty the effect of the fabricated 3D environment in cell 
behavior. In the future, it is intended to achieve a better usage of the 3D biomimetic models’ potential 
for the repair and regeneration of tissues, as well as the understanding and cure of pathologies; as in 
specific, the results obtained are expected to contribute to the development of neuronal and vascular 
biomimetic models, either singular or combined, for in vitro studies and regenerative applications. 
 
Keywords:  
Tissue Engineering, fibrin, heparin, hydrogel, electrospinning. 
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Chapter 1: General Introduction 
 
 
1.1. The origin of TE 
 
The dream is as old as humankind. From the earliest documented evidences of ancient 
civilizations, it is clear that diseases, injuries, death and longevity are among humanity's oldest 
preoccupations (Weatherall et al., 2006). In recorded history, the desire of restoring damaged human 
bodies was already noticeable, and tissue and organ regeneration were already reported. Such could be 
observed in the phrases of Genesis, Chapter II, about the creation of Eve from Adam’s taken ribs by the 
Lord God (Battler et al., 2007). This idea was also manifested in the Greek myth of Prometheus, an 
individual who was punished by Zeus, enchained to mount Caucasus and tortured perpetually by an 
eagle who fed from his exposed liver every day after overnight regeneration (Chen et al., 1994). The 
saint-physicians Cosmas and Damian are also known by the “miracle of the black leg”, which is reported 
to be a successful replacement of a limb and restoration of its lost function in the third-century A.D. 
(Conolly et al., 2007).  
 
Modern surgery emerged in the final decades of the 19th century as Robert Koch and Louis 
Pasteur made discoveries that led to conclusions about how a certain germ could invade the body and 
cause a particular disease. As knowledge about the germ theory of diseases increased, the introduction 
and development of sterile techniques were carried in concurrency with the development of general 
anesthetic techniques and control of pain. This enabled courageous surgeons to innovate surgical 
techniques, saving and improving the quality of human lives by restoring missing functions through the 
replacement and rebuilding of human body structures (Vacanti, 2007). Techniques such as autografts 
and allografts have been revolutionary and lifesaving, but major limitations exist. As far as the 
harvesting of autografts is concerned, the quantity of tissue supply is a problem. The need of surgery at 
the donor site can also be a problem, since it might contribute to the occurrence of hemorrhages, 
infections, inflammations, general damages and pain. In the case of allografts, risks of rejection by the 
patient’s immune system are presented, as well as the possibility of disease transmission from the donor 
to the patient. Also, to the limited allografts available, none were reported with satisfying biological and 
mechanical properties which secured good segmental reconstruction and replacement (Steven J. Barnes, 
2008). These constraints have produced a need for novel therapies, and it is within this context that the 
field of TE has emerged. 
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1.2. The emergence of TE 
 
From the previous section, we can conclude that surgically-focused side of the field has a long 
history; however, inclusion of cells is a more recent development due to the lack of knowledge in 
molecular cell biology, a field that is only a few decades old. The conciliation of cell biology and 
experimental surgery is relatively recent and only in this century has TE advanced as a major area of 
research. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Growth of TE represented by the number of results returned per year from a Pubmed search for the keywords ”Tissue 
Engineering”. 
 
As observed in Fig. 1, the field of TE has only started to emerge in the late 1980s. Two broad 
biological categories in TE can be recognized: 
 modification of the growth and functions of cells in vivo, and 
 construction of bioartificial tissues in vitro with or without isolated cells. 
 
The purpose of the first category is the alteration of the growth and functions of cells in situ. As 
an example, it can be referred the case of Erba et al. (2010) who studied the neuroregenerative potential 
of undifferentiated rat adipose derived stem cells to enhance axonal growth and differentiation in a rat 
sciatic transection model. As for TE in vitro, it includes bioartificial tissues (i.e., tissues which are 
composed of natural and synthetic substances) to be used as an alternative to organ transplantation. 
Besides their potential clinical use, reconstructed support models (also referred as scaffolds) may also 
be used as biomimetic tools to study complex tissue morphogenesis and functions in normal and 
diseased conditions (Berthiaume, 2003). As an example, it can be mentioned the differentiation of rat 
adipose derived stem cells to a Schwann cell-like phenotype by Georgiou et al. (2015), in order to 
construct an aligned collagen hydrogel to support and guide neurite extension.  
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1.3. The Biomimetic Tissue Model 
 
One of the main goals of TE, if not the ultimate, follows the approach of the second broad 
category previously mentioned, and is to create a 3D biocompatible model/scaffold with cell adhesion, 
proliferation and/or differentiation properties that triggers no inflammatory responses or rejection from 
the body. Standard fabrication of functional, viable, complex and biomimetic tissue constructs would 
make a significant difference in Medicine. These could be implanted into defects to correct them, or 
used as a model to study the tissue response to drugs or in diseased conditions. Hence, it would be able 
to meet the growing demands for replacing and restoring various tissues and organs. As examples, it can 
be mentioned the work of Min. et al. (2014), who developed a 3D silk protein-based neural culture 
compatible scaffold, which provided relevant information about brain neural networks and showed 
capability for the assessment of brain disorders, such as traumatic brain injury. For cell therapy studies, 
Aratyn-Schaus et al. (2016) presented the hypothesis that newly formed myocytes exhibit a weaker 
contractile strength due to a possible reduction of force transmission between spared and newly formed 
myocytes. This was tested by creating and using a polyacrylamide hydrogel containing mouse 
cardiomyocytes to represent a spared myocardium tissue after injury. 
 
 
1.4. Thesis scope 
 
Although there have been tremendous efforts to replace and restore various parts of the body, 
most applications have not been successful since the scaffolds were not able to diffuse oxygen and 
nutrients to support and sustain cellular activity. Successful applications have been limited to thin and 
avascular tissues such as cartilage and skin, where oxygen and nutrients can diffuse within the constructs 
and sustain cellular viability. However, as the tissue becomes thicker, the distance between tissue-
specific cells and the network grows more than 200 µm (Malheiro et al., 2016), and hence the cells reach 
hypoxic and apoptotic conditions (Moon & West, 2008). Towards this aim, there have been numerous 
attempts to induce innervation and vascularization in engineered constructs (Fig. 2). 
a 
              
Fig. 2. Vascularized (A) and innervated (B) tissue construct schematic. Adapted from (Marrella et al., 2017). 
A B 
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Looking to understand the process of tissue growth of the vasculature, Doreen et. al created a 
model that consisted in parallel-arranged hollow polypropylene fibers colonized with endothelial cells 
(HUVECs) and vascular smooth muscle cells (HUASMCs) (Janke et al., 2013). Another and recent 
example is the study of Valarmathi et al. (2017) to test the possibility of generating a functional 
vascularized cardiac tissue, through the attempt of vascularization of a collagen scaffold with the 
interaction between human induced pluripotent stem cell-derived embryonic cardiac myocytes (hiPSC-
ECMs) and human adipose-derived multipotent mesenchymal stem cells (hMSCs). 
 
However, a scaffold must have the function of native blood and must provide appropriate 
mechanical, endothelialization and antithrombogenic properties. Therefore, choosing a proper 
biomaterial and designing a construct which provides these characteristics is crucial. 
To tackle this challenge, this thesis aims at optimizing fibrin hydrogels by heparin 
functionalization and addition of microchannels, resulting in constructs intended for neural and vascular 
applications. 
 
Studies of heparin-conjugated fibrin (HCF) hydrogels have already been conducted to form in 
vitro TE models, such as the loading of NGF into HCF gels to form NGF-delivering implants, or the 
creation of an injectable system for long-term delivery of BMP-2. (Lee et al., 2014; Yang et al., 2010). 
These two studies mainly provided inspiration, comparison and motivation to this thesis, focusing in the 
aim of improving and optimizing the fabrication and characteristics of HCF hydrogels. 
 
 
                 
 
Fig. 3. Embedded fibers in hydrogel (A) and schematic of promotion of vascularization (B). Adapted from (Muehleder et al., 
2014). 
 
The optimization of the hydrogels and the addition of microchannels with the purpose of 
creating space within the hydrogel might allow cells to grow unhindered, the passage of oxygen and 
nutrients, and facilitate the formation of vessels and/or neurites (Fig. 3). In this way, TE models become 
excellent supports for neural and vascular growth and orientation. 
 
Removable fibers 
A B 
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Fibrin can play the role of scaffold because it promotes cell attachment, cell proliferation, cell 
migration, exhibits excellent biocompatibility properties and its nontoxic degradation can be controlled. 
Additionally, fibrin scaffolds are self-assembled into complex polymeric networks with controllable 
mechanical properties and stability through precursor’s ionic strength and concentration. Through the 
functionalization with heparin, which has high affinity and immobilization properties to capture growth 
factors such as VEGF and NGF, the release of these might be controlled. 
Heparin is a sulfated glycosaminoglycan (GAG) isolated from a variety of natural sources with 
a strong anticoagulant activity. Combined by glycosidic linkages, it is composed of alternate units of α-
D-glucosamine and uronic acid, either α-L-iduronic acid or β-D-glucuronic acid (Dreyfuss et al., 2009). 
The structure of heparin’s chains enables the interaction with a specific range of proteins, allowing the 
modulation of different cellular processes. Heparin interacts with growth factors and fibrin, which may 
result in a significant prolonged release of the growth factors locally presented to the cells. Hence, it is 
possible to achieve an optimal environment for the adhesion, migration, orientation and proliferation of 
cells (Fig. 4). 
 
 
Fig. 4. Schematic of heparin-conjugated fibrinogen hydrogel formation with growth factors. Adapted from (Ma et al., 2015). 
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 Electrospinning was the chosen method for the fabrication of microfibers, since electrospun 
microfibers may provide large surface area to volume ratios, allowing cell adhesion and proliferation, 
pore sizes tailored to specific cells dimensions, functionalized surfaces, multiple sites for interaction and 
attachment, and low mass transfer limitation. As for the microfibers material, pNIPAM is a prominent 
candidate as thermoresponsive polymer widely known for its lower critical solution temperature (LCST) 
phenomenon at 32°C in aqueous solutions. Hence, the microfibers may be embedded within the HCF 
hydrogel and triggered removal achieved by lowering the temperature below the LCST thus forming 
microchannels. 
In this sense, a microchanneled hydrogel to induce innervation and vascularization for a 
functional and viable construct could be provided. 
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1.5. Thesis overview 
 
For a better reading experience, this section aims to describe the structure and relevance of each 
chapter of this thesis. The thesis is divided into six chapters. 
 
Chapter 1 presents a general introduction, which includes the history and importance of the TE 
field, narrowing to the introduction of biomimetic tissue constructs and the specific thesis scope. 
 
Chapter 2 is specific to tissue constructs, providing enlightenment about the significance of 
scaffolds in TE, and emphasizing the complexity of the scaffold design process and the need of criterion 
deliberation (fabrication methods, materials...) according to end applications. The hydrogel formation 
with Fibrin and the addition of VEGF growth factor are specially highlighted in this chapter. 
 
Chapter 3 introduces Electrospinning by referencing history facts, describing the technique and 
its importance in the TE field. Important parameters in taking to account in order to obtain an expected 
electrospun result are mentioned. Smart biomaterials are introduced, with pNIPAM specially 
highlighted. Finally, the aligned channeling idea is described. 
 
The experimental chapters are presented by chapters 4 (fabrication, characterization of the HCF 
hydrogel, and tenocytes seeding in HCF hydrogel) and 5 (fabrication of electrospun pNIPAM 
microfibers). Each of them have a composition of four sections: an introduction to describe and explain 
the aim of the experiment, a materials and methods section, followed by the presentation of results and 
a last section for discussion of the results and overall experiment. 
 
Finally, Chapter 6 is reserved for the conclusion of the thesis, by presenting a summary of 
findings, overall limitations and future perspectives. 
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Chapter 2: Scaffolds 
 
 
2.1. Introduction 
 
This chapter aims to review the important properties and fabrication techniques of scaffolds, 
with special attention to biomaterials selection and cell seeding approaches. Additionally, the specific 
biomaterials and fabrication methods adopted in the various chapters of this thesis will be highlighted. 
 
Scaffolds are 3D (3D) models, supports, templates or constructs developed to mimic the 
extracellular matrix (ECM) for new tissue formation and remodeling. The design and fabrication of 
scaffolds are major areas of biomaterial research. 
 
 
Fig. 5. Hydrogel scaffold schematic. Adapted from (Zheng et al., 2016). 
 
With the progress of the TE field, the need for novel scaffold constructs and fabrication 
techniques has become of paramount importance. Nowadays, researchers may encounter an enormous 
variety of scaffold approaches for TE. 
 
The optimal scaffold is one that:  
 
 is formed by a material with controlled biodegradability or bio-resorbability; 
  presents appropriate chemistry properties to favor cellular growth, attachment, 
differentiation and proliferation; 
 possesses inter-connecting pores of an adequate size and scale to allow and promote 
tissue integration and vascularization; 
 has adequate mechanical properties to match the specific extracellular matrix 
environment in study; 
 does not induce any negative biological response; 
 is easily fabricated in diverse shapes and sizes to fulfill several application needs (Liu 
et al., 2007; Sachlos et al., 2003). 
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2.2. Materials 
 
One of the first considerations when designing a scaffold for TE is the choice of the material. 
The three main material types which have been successfully investigated to be applied in developing 
scaffolds include: 
 natural polymers, 
 synthetic polymers, and 
 ceramics (Willerth & Sakayama-Elbert, 2007; Radulescu et al., 2007). 
 
However, polymers show more versatility and similar structural characteristics of the ECM, and 
that is why they are the main material type which has been the most successfully investigated to be 
applied in overall developing scaffolds. Polymers can be divided into natural or synthetic polymers of 
according to their source (Chen et al., 2013). Natural polymers’ main advantage is that they are similar 
to organic constituents and are recognized by the host cells in order to give rise to positive cellular 
interactions. However, natural polymers present variability between batches, being their composition 
variable according to the extraction source and, in addition, because of the potential risk of 
immunogenicity, they need to undergo a purification process before being applied (Willerth & 
Sakiyama-Elbert, 2008). Synthetic polymers have the advantage of being obtained by controllable 
chemical processes. These are usually simple and allow large-scale production without variations 
between batches, and make it possible to shape some characteristics such as degradability, and 
mechanical properties of the formed network, according to the characteristics of the tissue to be replaced 
(Willerth & Sakiyama-Elbert, 2008). 
 
2.2.1. Natural Polymers 
 
Within the natural polymers, three groups can be distinguished: polysaccharides, 
polynucleotides and polypeptides (Yadav et al., 2015). 
 
Alginate is a polysaccharide extracted from algae. Structurally, it is a linear copolymer 
composed of α-L-guluronic acid units and β-D-mannuronic acid linked by bonds (1 → 4). Due to its 
biocompatibility, low toxicity, ease of gelling and low cost, this polysaccharide was chosen to be used 
in many applications in the biomedical area. In tissue regeneration, alginate has been applied in the 
regeneration of bone (Rubert et al., 2012; Zhao et al., 2010), cardiac (Dahlmann et al., 2013), cartilage, 
and skin tissue (Slaughter et al., 2009; Straccia et al., 2015). As an example, is the study of Dahlmann 
et al. (2013) related to the modification of physical and mechanical properties of the hydrogels. Through 
this study, it was found that the scaffold properties could be adjusted with the derivatization, change in 
the concentration and composition of blended polymers (alginate and hyaluronic acid). It was also 
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observed that the addition of collagen allowed adhesion, proliferation and integration of the cells into 
the formed matrix, allowing the formation of a new tissue with characteristics similar to myocardium. 
Hence, it was observed that the blended polymers had a great potential of its general properties 
adjustments, allowing the optimization of the matrix so as to better mimic the myocardium. 
 
 
 
Fig. 6. Chemical structure of alginate. From “Chemical Structure « Alginate « KIMICA corporation | manufacturer and 
world-wide supplier of "Alginate / Alginic acid" Alginic Acid, Propylene Glycol Alginate, Calcium Alginate, (2017)”. 
 
 
Chitin is the second most abundant natural polymer on planet Earth, right after cellulose, and it 
can be found in the exoskeleton of insects and crustaceans. Structurally, it is presented as a linear chain 
polysaccharide composed of glucosamine monomeric units and β-linked N-acetyl-D-glucosamine units 
(1 → 4). From chitin’s deacetylation, chitosan can be obtained, which presents a higher proportion of 
glucosamine units compared to chitin (Laranjeira & Fávere, 2009; Synowiecki & Al-Khateeb, 2003). 
 
Both chitin and chitosan present no toxicity and have biodegradable, biocompatible and low 
immunogenic properties. However, unlike chitosan, chitin is insoluble in most solvents due to the 
hydrogen bonds it possesses (Pillai et al., 2009). Hence, chitosan has been the one most used and applied 
in TE not only because of the previous mentioned properties, but also because of its hydrogel formation 
capacity. Through the study of Levengood and Zhang (2014), it was recognized chitosan’s potential for 
bone TE. Chitosan allowed the adhesion and proliferation of osteoblasts and the formation of a bone 
matrix mineralization. Lisková et al. (2015) also studied the application of chitosan to bone regeneration 
by developing injectable chitosan hydrogels containing sodium and magnesium glycerophosphate. The 
hydrogels demonstrated cytocompatibility and the potential for this application. 
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Fig. 7. Chemical structure of chitin and chitosan (obtained after chitin’s deacetylation). From (Zuber et al. 2013). 
 
Collagen is the most widely used natural polypeptide polymer. Its composition is denoted by a 
family of proteins composed of three polypeptide chains arranged as a triple helix. There are more than 
twenty types of collagen (Gelse et al., 2003), and among these, the most abundant are collagen type I 
and III. Collagen hydrogels can be formed by physical crosslinking or chemical crosslinking. They are 
thermally reversible when they are obtained by physical crosslinking. This polymer can present some 
limitations, being necessary the optimization of some characteristics according to the tissue that is 
intended to regenerate. Since it presents a high rate of degradation, its hydrogels will have less stability 
and reduced mechanical resistance. The disadvantages of these hydrogels are that they are potentially 
immunogenic, require a costly purification process, present a high rate of degradation, low signs of 
mechanical strength and, hence, low stability. However, collagen has still been widely used in TE due 
to its biocompatible and biodegradable properties.  
 
As an example, Ma et al. (2016) prepared a hydrogel containing collagen, hydroxyapatite and 
alendronate, a drug used for the treatment of osteoporosis. The hydrogels were synthesized using as an 
organic compound named genipine as a crosslinking agent. Hydrogels with different ratios of 
hydroxyapatite and alendronate were prepared and the results obtained were compared. The hydrogels 
presented biocompatibility, biodegradability and good mechanical properties, and these could be 
adjusted through the modification of hydroxyapatite and alendronate proportions, and also through the 
alteration of the crosslinking agent’s concentration. In resume, these hybrid hydrogels promoted cell 
adhesion and proliferation in this in vitro study, and showed potential for application as bone scaffolds 
for TE. 
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Fibrin is a natural polymer obtained from fibrinogen, a large, complex and fibrous glycoprotein 
protein in plasma which has a key role in many biological processes such as hemostasis, inflammation, 
wound healing and angiogenesis. It is composed of two sets of three polypeptide chains (Aα, Bβ, and 
γ). It also includes two fibrinopeptides connected by 29 disulfide bonds within the E domain, A and B. 
One and two interchain disulfide bond(s), respectively, link α and γ chains to the same chains of the 
opposite subunit. Via a disulfide bond, the β chain of one subunit is linked to the α chain of the other 
subunit. In the other hand, a second β chain is connected to the γ chain of the opposite subunit via an 
additional disulfide bond. Hence, the two β chains are not directly linked to each other. The fibrinogen 
protein is approximately 45 nm long and it contains two identical outer D domains, each connected to 
the central E domain, which contains the two pairs of fibrinopeptides, by a coiled-coil segment (Noori 
et al., 2017). 
 
 
 
Fig. 8. Fibrinogen's structure. Aα chains are shown in blue, Bβ chains are shown in green and γ chains are shown in red. 
Disulfide bridges stabilizing the coiled-coil regions are shown in yellow. Adapted from (Noori et al., 2017). 
 
Fibrin is an ideal candidate for TE applications since it possesses remarkable advantages over 
other biomaterials (Noori et al., 2017).  Fibrin gels are rapidly assembled by a modified 
polycondensation reaction from fibrinogen. Fibrinogen removes the part of the fibrinogen polypeptides 
that prevent its spontaneous polymerization as soon as the clotting enzyme thrombin is activated in the 
clotting cascade (Janmey et al., 2009). 
The clotting/coagulation cascade is composed by reactions that initiate after blood contact with 
a foreign material or upon injury (Schenone et al., 2004). Thrombin is the protease generated in the last 
step of the clotting cascade that cleaves short peptide strands from the central region of the fibrinogen 
molecule into fibrin monomers. 
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Fig. 9. Schematic of fibrin polymerization. Adapted from (The University of Utah, 2017). 
 
These monomers spontaneously associate together into long strands called protofibrils which 
can perform a lateral assembly of thicker fibers branches when sufficiently long. As a result, gelation 
occurs, and a 3D fibrin network is obtained (Fig. 9). 
 
Fibrin possesses multiple interaction sites for cells and other proteins and its properties can be 
controlled by manipulating polymerization conditions such as pH, ionic strength and modifying the 
concentrations of the precursors (fibrinogen and thrombin) solutions, an important feature for scaffolds 
design (Noori et al., 2017). The modification of polymerization parameters also affects biochemical 
cues in fibrin, such as the concentration and distribution of ECM ligands, cytokines, and growth factors. 
These may affect the properties of cell growth, proliferation, differentiation, and expression of growth 
factors. Cell behavior may also be affected by physical cues such as matrix stiffness (Reinertsen et al., 
2014). Hence, fibrin is allowed it to act as a bioactive matrix, becoming suitable for cell functionality, 
delivery and support. 
 
 
2.2.2. Synthetic Polymers 
 
In the synthetic group, countless polymers are included, and the most widely used in TE are 
polylactic acid (PLA), polyglycolic acid (PGA) and poly (ethylene glycol) (PEG). 
 
Poly (ethylene glycol) (PEG), also known as poly (ethylene oxide), is a biocompatible, with 
high permeability hydrophilic polymer, that has low immunogenicity and allows the diffusion of 
nutrients (Lin & Anseth, 2009; Slaughter et al., 2009). Due to these properties, it has been used in 
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biomedical applications such as scaffolds for the development of new tissues and matrices for the 
controlled release of biomolecules (Lin & Anseth, 2009). In the field of TE, PEG is used for the 
formation of hydrogels with highly swelling capacity, resulting in a high-water content construct with 
viscoelastic properties similar to soft tissues. This creates an environment similar to the extracellular 
matrix (Papavasiliou et al., 2012) and adequate to cellular applications. The advantages of this polymer 
are the possible chemical modifications in order to change some of its characteristics, such as mechanical 
resistance. (Lin & Anseth, 2009).  
 
Dahlin et al. (2014) evaluated the attachment and viability of human fibroblasts to test the 
influence of the modification of the hydrogels with argininaglycine-aspartic acid in adhesion and cell 
survival. The hydrogels were formed with three different in vitro degradation times (28, 60 and 120 
days), with or without addition of the arginine-glycine-aspartic acid sequence. Cell viability was 
determined by measuring the concentration of the enzyme lactate dehydrogenase (LDH), a cell 
membrane breakpoint marker. After 13 days of the beginning of the study, a decrease in the number of 
cells in all the hydrogels studied was visualized, and the hydrogels with a degradation time of 60 days 
showed a higher LDH value than the rest. 
 
In conclusion, all PEG formulations studied showed a similar behavior, except formulations 
with a degradation rate of 60 days. Hence, there is a possibility of applying PEG hydrogels to guided 
bone regeneration, however, it is necessary to optimize the degradation time of the hydrogel (Dahlin, 
Johansson, Hoffman, & Molenberg, 2014). 
 
The polyglycolic acid (PGA) is a rapidly degradable polymer with a glass transition temperature 
from 35 to 40°C. In the other hand, the polylactic acid polymer (PLA) has a higher glass transition 
temperature between 60 and 65°C, and has an additional methyl group which gives it greater 
hydrophobicity and stability to hydrolysis. The acopolymer formed by units of polylactic acid and 
polyglycolic acid is called polylactic-co-glycolic acid (PLGA) (Ulery et al., 2011). It is the synthetic 
polymer most frequently used for bone regeneration, and can be developed in the form of scaffolds, 
coatings, fibers or microspheres (Félix Lanao et al., 2013). It has the advantage of being composed of 
the two polymers, presenting a combination of both properties, and these are open to optimization 
through changes in the proportion of each polymer (Ulery et al., 2011). 
 
As an example, the hydrogel composed of PLGA and PEG created by Yan et al. (2015) can be 
mentioned. A heat-sensitive PLGA-PEG-PLGA hydrogel loaded with simvastatin was developed for 
bone regeneration applications. Simvastin has an effect on the differentiation and mineralization of 
osteoblasts, having a positive effect on the formation of bone tissue (Walter et al., 2014; Yang et al., 
2011), hence why the loading of this drug was decided by the authors. The hydrogels were synthesized 
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with and without simvastatin, and in vitro and in vivo studies were performed using a mouse derived 
osteoblast cell line (MC3T3-E1). Cell proliferation and differentiation were observed, with higher 
mineralization and expression of the osteogenic gene in the case of the hydrogel loaded with simvastatin. 
Bone formation was found in tibial defects injected with PLGA-PEG-PLGA hydrogel containing 
simvastatin, compared to the hydrogel without simvastatin and control. In conclusion, the results 
obtained points that the application of PLGA-PEG-PLGA hydrogels containing simvastatin could be 
used as a therapeutic alternative for bone tissue regeneration (Yan et al., 2015). 
 
 
2.3. Growth Factors 
 
Growth factors are signaling molecules that control a variety of cellular functions (Vo et al.,  
2012) such as growth, proliferation and migration (Zhao et al., 2015). As previously mentioned, 
scaffolds are intended to mimic the natural ECM’s structure, surface morphology and chemistry 
properties to achieve improved cell-matrix interactions and new tissue formation. The delivery of 
growth factors from a scaffold is an attractive strategy for TE, since growth factors, if properly integrated 
in the 3D system, may be able to directly stimulate cellular activities. Hence, besides its structural 
purposes, the scaffold serves as a delivery carrier for the controlled release of growth factors. 
  
Some growth factors are small peptides called cytokines, but only those affecting cell growth 
and differentiation signaling pathways are the ones considered as growth factors. (Stone & Bhimji, 
2017). Vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), fibroblast 
growth factor (FGF) and epidermal growth factor (EGF) are examples of protein growth factors. 
 
The vascular growth factors play a significant role in physiological and pathological 
angiogenesis (Dvorak et al., 1995). Several molecules that stimulate angiogenesis have been identified, 
however, we will focus on VEGF, since it was the growth factor chosen to work with in this thesis. 
VEGF acts essentially on the regeneration of vascular tissue, but it also assists in the regeneration of 
nerves, since during the regeneration process, there is a close relation between the nerve fibers and the 
blood vessels. The blood vessel infiltration in nerve conduction chambers is significantly increased by 
the addition of VEGF, consequently increasing the Schwann cells migration and axonal regeneration 
(Hobson et al., 2000; Terenghi et al., 1995). VEGF can also act as a neuroprotectant in neurons in vivo 
and in vitro after ischemic injury (Wongtrakul et al., 2002). There is evidence that this growth factor 
has neuroprotective and neurotrophic effects on neuronal and glial cells not only in culture but also in 
vivo, hence possibly stimulating and promoting stem cell survival and proliferation (Jin et al., 2000). 
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VEGF showed to have a significant role in the response to cerebral and peripheral ischemia, since it is 
capable of promoting nerve repair after traumatic spinal cord injury.  
 
As an example, the study of Wongtrakul et al. (2002) about the effect of VEGF on conventional 
nerve grafts’ angiogenesis and neovascularization can be mentioned. A 2.5 cm segment was removed 
from the sciatic nerve and orthotopically repaired. After 3 days, a significant percentage of the control 
nerves and all the nerves treated with VEGF presented signs of partial longitudinal neovascularization. 
Other studies have investigated the effects of VEGF on rat sciatic nerve regeneration in vivo. The grafts 
were pretreated with VEGF, NGF or laminin prior to implantation. Grafts pretreated with VEGF 
stimulated the growth of Schwann cells and blood vessels, but not axons. This work points towards the 
relevance of local application of VEGF to promote the proliferation of Schwann cells and 
neovascularization, both very important during nerve regeneration (Zachary, 2005). 
 
To mimic the ECM behavior and achieve a viable functionality of tissues in the long-term, 
efforts to control the retention and release of growth factors have engaged several biomaterial 
approaches including strategies of ionic complexation, covalent conjugation, affinity binding or physical 
entrapment of growth factors within polymer scaffolds (Vo et al., 2012). 
In this thesis, the strategy of functionalizing fibrin with heparin in order to take advantage of 
the polysaccharide’s high affinity properties was applied. The chains of heparin are known to interact 
with a variety of proteins such as heparin-binding growth factors (e.g. VEGF and NGF), morphogens, 
pathogens, extracellular matrix components, among many others. The heparinization is a crucial step of 
the HCF hydrogel formation to enable a prolonged and controlled bioactivity and release of the growth 
factors, as well as GFs’ protection from proteolytic degradation (Jha et al., 2015). Consequently, an 
optimal environment for the adhesion, migration, orientation and proliferation of cells may be achieved. 
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Chapter 3: The Electrospinning Technique 
 
 
3.1. Introduction 
 
In recent decades, the electrospinning technique, also known as electrostatic spinning, has 
attracted great interest due to its capability of processing a vast range of polymeric materials in form of 
nanofibers in an easy and effective manner (Zhang et al., 2017). The significance of nanofibers comes 
from the inherent properties such as the extremely high surface to volume ratio, and the engineered 
properties such as fiber diameter, porosity, stability, hydrophilicity, and permeability. There are various 
processes for nanofiber fabrication available, such as self-assembly and phase separation. However, 
electrospinning shows versatility and flexibility in terms of material selection and control over fibers’ 
morphology and diameter, which is why this technique is regarded as the most attractive for designing 
of natural and synthetic polymer-based nanofibers for TE (Naves et al., 2017; W. Zhang et al., 2017). 
In addition, it has the possibility of forming various fiber network patterns, including aligned, nonwoven 
or custom-patterned fiber meshes, three dimensional (3D) structures, among others. These 
characteristics make electrospun microfibers elected for applications in sensors, energy, biomedicine, 
among others (W. Zhang et al., 2017). 
 
3.2. History 
 
The electrospinning technique was discovered and described as a derivative of electrospraying, 
a method that utilizes electrostatic forces to generate polymer droplets. Geoffrey Taylor published a 
study in 1964 which explained, in the presence of an electric field, the deformation of water droplets. 
He was able to demonstrate the distortion of spherical drops into conical shapes through his 
mathematical reasoning. In 1969, another article of his own was published focusing on the formation 
and ejection of fine jets from viscous solutions. In the late 1970s, Annis et al. (2016) investigated 
specifically for potential vascular prostheses but, overall, the electrospun polyurethane fibers obtained 
were not considered to have many useful applications. The technique grew weak for many years until 
the early 1990s. Interest was renewed mainly because of the need for a process which would enable the 
fabrication of fibers at the nanometer scale. In this way, many researches such as Reneker and Yarin 
(2016) began to examine the fibers that were formed attention by this process with a more precise and 
investigate the physics conducting their formation. 
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3.3. The Process 
 
To produce fibers, two standard set-ups, vertical and horizontal, are currently available. Both 
consist of four major components: a high-voltage power supply, a syringe with a metallic needle, a 
syringe pump and a grounded collector (Fig. 10). Through the syringe, a polymer solution is dispensed 
at a constant rate into a high voltage electrical field generated between the end of the needle and the 
collector. As it is dispensed a polymer solution droplet forms at the end of the needle tip, which when   
subjected to the electrical field, elongates into a conical shape named Taylor cone. When the repulsive 
electrical forces overcome the surface tension forces, an electrified polymer jet ejects from the apex of 
the cone. The jet is then elongated and whipped continuously by electrostatic repulsion forces. 
Therefore, the electrospinning process is conducted by a variety of forces between charges on the jet 
surface, e.g. the viscoelastic force of the solution, the surface tension, the electrostatic force due to the 
external electric field, and the gravitational force (Sapountzi et al., 2017). 
 
 
Fig. 10. Schematic of electrospinning in typical horizontal (a) and vertical set-ups (b). From (Sapountzi et al., 2017). 
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The technique is highly versatile since, besides the conventional non-oriented fibers, a variety 
of morphologies (e.g. fiber diameter…) and structures (e.g., aligned or crossed fiber arrays, ribbon, 
necklace-like, nanowebs, hollow, helical or coil fibers…) can be obtained by modifying electrospinning 
conditions or set-up (e.g., polymer concentration, voltage, flow rate, distance between capillary and 
collector…) (Sapountzi et al., 2017) (Fig. 11). 
 
 
 
 
Fig. 11. Fiber diameter in proportion to polymer concentration, voltage or flow rate (A), and fiber diameter in proportion to 
distance between capillary and collector (B). From (Sapountzi et al., 2017). 
 
 
3.4. Materials 
 
The choice of polymer represents a key component in the development of sustained release 
electrospun fibers. The seemingly unlimited number of natural and synthetic polymers that can be 
electrospun highlights the versatility of this platform. Therefore, the intended application for the 
sustained release fibers often dictates the polymer selection. Both non-biodegradable and biodegradable 
polymers have been used for sustained release from electrospun fibers (Chou et al., 2015). To date, more 
than 200 polymers have been successfully electrospun to nano-scale or micro-scale fibers, including 
natural materials (e.g., collagen, gelatin, hyaluronate (HA), chitosan, silk fibroin (SF), etc.) and synthetic 
materials (e.g., polycaprolactone (PCL), poly-L-lactic acid (PLLA), poly(lactide-co-glycolide) (PLGA), 
polyethylene oxide (PEO), etc.) (Kong & Mi, 2016). 
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3.4.1. Smart biomaterials and pNIPAM 
 
 
Stimuli-responsive polymers, also known as “smart” polymers, demonstrate rapid changes in 
their microstructure from a hydrophilic to a hydrophobic state, once triggered by changes in the 
environment. External stimuli such as heat, pH, ionic strength, magnetic and electric fields, light, 
ultrasound, and chemical species trigger changes in the environment. The system is capable of returning 
to its initial state when the trigger is removed because the macroscopic changes are reversible (Panambur 
et al., 2017). The use of the terms “smart” and “intelligent” to describe the materials came from the 
USA. The smart materials had been around for decades, but the use of the terms only started in the 
1980s. Early applications of these materials started with technologies that involved the use of nickel as 
a sonar source during World War I to find German U-boats by Allied forces (Badami & Ahuja, 2014). 
Smart biomaterials have been around for many years and they have found many applications ever since. 
In this thesis, we will focus on pNIPAM, which was the chosen polymer for the fabrication of 
microfibers. 
 
Poly(N-isopropylacrylamide) (pNIPAM) is one well studied smart biocompatible and 
temperature responsive polymer, which exhibits a lower critical solution temperature (LCST) at 32°C. 
At temperature above the LCST, the intermolecular hydrogen bonding between the pNIPAM chains and 
water molecules is replaced by intramolecular hydrogen bonding between CO and N–H groups along 
the pNIPAM chains. This results in compact and collapsed chains that interact minimally with water 
and, thus, exhibit hydrophobicity.  In contrary, the ionic moieties interact strongly with the media below 
the LCST, and result in hydrophilicity (Patra et al., 2016). 
 
 
 
Fig. 12. Plot of transmittance as a function of temperature for P(N-isopropylacrylate-co-5% methacrylic acid) , 1% aqueous 
solution, pH = 4.46. From (Panambur et al., 2017). 
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3.5. Parameters 
 
One of the great advantages of electrospinning is that the morphology of the electrospun 
nanofibers can be easily controlled by changing the parameters during the electrospinning process (Chen 
et al., 2017). Many processing parameters such as: 
 the chemical nature of the polymer solution (molecular weight, solvent and 
concentration); 
 the applied voltage; 
 the distance between the syringe needle tip and the collector; 
 the flow rate; 
 the humidity and, 
 the temperature may affect the morphology of the fibers (Kong & Mi, 2016). 
 
The concentration of the polymer is an important parameter since it determines the morphology 
of the electrospun fibers. The surface tension can be as dominant as the polymer concentration decreases. 
In addition, solution viscosity is another critical parameter, as it determines if the polymer can be 
electrospun into fibers or not. The solution viscosity is highly dependent on the concentration and the 
molecular weight of the polymer used. In principle, a polymer with higher molecular weight has, on 
average, longer molecular chains. Thus, it will form more entanglements which will lead to a higher 
viscosity of the polymer solution. In the case of solutions prepared with high molecular weight polymers, 
if the polymer concentration is low, it still can produce a uniform jet due to a sufficient level of solution 
viscosity. In the opposite hand, if the molecular weight is too low, even with a high polymer 
concentration, an appropriate polymer solution viscosity cannot be guaranteed. The polymer will tend 
to form a bead structure on the collector. Processing conditions such as applied voltage and flow rate 
also play a significant role in fiber formation during electrospinning (Chen et al., 2017). 
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3.6. Aligned Channeling 
 
In concern to vascular and neural regeneration, scaffolds with high alignment exhibit impressive 
advantages in terms of their mechanical properties and cell proliferation processes, such as cell 
orientation, migration, and differentiation.  Highly-aligned fibers play a crucial role in neurite outgrowth 
of the neural cell when compared to randomly-distributed fibers (Chaurey et al., 2012; Yang et al., 
2005). Neurite outgrowth, cell migration and the extracellular matrix deposition of the neural cells on 
the aligned fibers tend to stretch in a parallel direction along the alignment of the nanofibers (Huang et 
al., 2015; Jha et al., 2011; Kim et al., 2016; Zhao et al., 2011).  
 
A way to create longitudinally oriented channels is to create a construct from one polymer with 
embedded aligned oriented fibers from another polymer, and then selectively dissolve the fibers to form 
oriented channels (Biazar et al., 2010). As an example, the study conducted by Yu et al. (2005) can be 
mentioned. It involved HEMA, which was copolymerized with ethyl methacrylamide (AEMA) to create 
a P(HEMA-co-AMEA) gel. PCL fibers were embedded in the gel, and then selectively dissolved by 
acetone with sonication to create channels. When compared with scaffolds without channels, the 
addition of 82–132 channels could provide an approximately 6-9 fold increase of surface area, which is 
advantageous for regeneration studies that depended on contact-mediated cues (Yu & Shoichet, 2005).  
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Chapter 4: Fabrication and Characterization of HCF Hydrogel 
 
 
4.1. Materials and Methods 
 
 
4.1.1. Synthesis of heparin-conjugated fibrinogen 
 
N-Hydroxysulfosuccinimide sodium salt (NHS, 5 mM, Sigma-Aldrich, 56485) and N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 2 mM, Sigma-Aldrich, E1769) were 
dissolved in a 2-(N-morpholino)ethanesulfonic acid buffer solution (MES, 0.1M, pH 6.5, Sigma, 
M3885). Immediately, 0.1% w/v of heparin sodium salt from porcine intestinal mucosa (Sigma, H3149) 
was dissolved in the previous solution and reacted for 30 m at room temperature (RT) under agitation 
for activation of the heparin’s carboxylic acid groups. 0.1% w/v of fibrinogen from bovine plasma 
(Sigma, F8630) was added to the resultant solution and left to react overnight at RT. The resultant 
heparin-conjugated fibrinogen (HCF) product was recovered through precipitation with large excess 
acetone anhydride, centrifugation at 20ºC and 7874 rpm speed for 35 m, followed by vacuum drying for 
24 h at 20ºC. The resultant dried product was dissolved in phosphate buffered saline (PBS), dialyzed 
through a Spectra/Por® 7 dialysis membrane tubing (MWCO of 25 kDa, Spectrum) for 24 h in MilliQ 
water at 4ºC (with water changes every 2-4 h), and lyophilized for 48 h. 
 
4.1.2. Preparation of samples for 1H-NMR spectroscopy 
 
Samples of (1) pure fibrinogen, (2) activated heparin and (3) HCF were prepared by dissolving 
7 mg of each product in a solution of deuterium oxide. The 1H-NMR spectra were recorded on a NMR 
Bruker Ascend 400/Avance III spectrometer and analyzed in TopSpin 3.5pl7 software. 
 
4.1.3. Preparation of samples for FTIR spectroscopy 
 
5 mg of (1) pure fibrinogen, (2) activated heparin and (3) HCF were reserved, enough to cover 
the spectrometer’s sample compartment. The FTIR spectra of the samples were recorded on a FTIR 
Nicolet iS50 spectrometer. 
 
4.1.4. Formation of modified fibrinogen matrices in different concentration ratios 
 
10.5 mg/ml of pure fibrinogen and 10.5 mg/ml of HCF were prepared and mixed 1:1 with a 
thrombin solution (10U/ml plus 5mM calcium chloride). The matrices were prepared in the following 
percentages: 0%, 10%, 40%, 50%, 75% and 100% of HCF; with a total volume of 200µl in a 48-well 
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microplate. Immediately, the solutions were gently mixed to disperse them homogeneously trough the 
well and avoid bubble formation. Thereafter, the plate was incubated at 37⁰C until gel formation.  
 
4.1.5. Tracking of matrices’ gelation time 
 
In order to track the matrices’ gelation speed, the samples were observed every 15 minutes. The 
gelation time of each sample was registered. After gel formation, the samples were covered in a volume 
of 500 µl of Phosphate Buffered Saline (PBS) for gel hydration. 
 
4.1.6. Staining of matrices with Alcian Blue 
 
An alcian blue dye solution (pH 2.5) was prepared by adding 1 g of Alcian Blue to 100 ml of 
3% Acetic Acid. After the removal of PBS from the samples, the dye solution was added to each sample 
and left at RT for 30 m. The staining solution was removed and the wells washed with PBS until the 
PBS washing solution became clear. Sample images were captured with a Nikon SMZ25 
stereomicroscope.  
 
4.1.7. Heparin quantification with 1,9-Dimethyl-Methylene Blue (DMMB) 
 
Three solutions in PBS of the following products were prepared: (1) fibrinogen (10.5 mg/ml) 
with non-conjugated heparin (6.75 mg/ml), (2) modified (heparin-conjugated) fibrinogen (10.5 mg/ml) 
before dialysis, and (3) modified (heparin-conjugated) fibrinogen (10.5 mg/ml) after dialysis. To prepare 
DMMB dye solution, 16 mg of DMMB, 3.04 g of Glycine and 2.37 g of NaCl were dissolved in 800 ml 
of MilliQ. The solution was stirred vigorously and titrated to pH 3.0 with 0.1 M acetic acid. MilliQ was 
added up to a total volume of 1 L. The heparin standard solution was prepared by dissolving 5 mg of 
heparin in 1 ml of PBS. The solution was diluted, and volumes were pipetted into a 96-well plate 
correspondent to heparin concentrations from 0-5000 µg/ml. The samples were pipetted and stained 
with DMMB dye. The microplate was placed on a Clariostar Monochromator Microplate reader with 
60 seconds of agitation before measurement of absorbance at 525 nm. 
 
4.1.8. Heparin leaching test with DMMB 
 
Four solutions in PBS of the following products were prepared: (1) pure fibrinogen (10.5 
mg/ml), (2) fibrinogen (10.5 mg/ml) with non-conjugated heparin (6.75 mg/ml), (3) 50% modified 
(heparin-conjugated) fibrinogen, and (4) 75% modified (heparin-conjugated) fibrinogen. A volume of 
100 µl of each solution was placed in a 48-well microplate in triplicate. The solutions were gently mixed 
with thrombin solution (10U/ml plus 5mM calcium chloride). Thereafter, the plate was incubated at 
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37⁰C until gel formation. The gels were covered with 1 ml of PBS for hydration and kept in a 37ºC 
incubation. 1, 3 and 5 days after the gels preparation, 500 µl of the supernatant were collected per well 
and replaced with fresh buffer. On day 5, 200 µl of human plasmin (0.006 U per 200 µl volume of gel) 
were added to each gel and incubated overnight at 37ºC to induce gel degradation. A volume of 200 µl 
of sample and the same volume of DMMB dye solution were pipetted to a microplate, which was placed 
on a Clariostar Monochromator Microplate reader with 60 seconds of agitation before measurement of 
absorbance at 525 nm. 
 
4.1.9. VEGF-A release profile based on ELISA 
 
A VEGF-A in PBS solution was prepared with a concentration of 120 ng/ml. Three solutions in 
PBS were prepared: (1) pure fibrinogen (10.5 mg/ml), (2) 50% modified (heparin-conjugated) 
fibrinogen, and (3) 75% modified (heparin-conjugated) fibrinogen; and mixed with thrombin solution 
(10U/ml plus 5mM calcium chloride). The gels were prepared as previously described. Samples in 
triplicate were prepared in a microplate and in eppendorfs, and covered with 500 µl of buffer. A 
microplate was kept on 37ºC incubation in a static condition while eppendorfs were kept in a microplate 
shaker at 37ºC under agitation at a speed of 50 rpm. 1, 3, 5 and 7 days after the gels preparation, 500 µl 
of the buffer solution in each well were collected and replaced with fresh buffer. Each collected solution 
was stored at -20ºC. On day 10, 200 µl of human plasmin (0.006 U per 200 µl volume of gel) were 
added to each gel and incubated overnight at 37ºC. The next day, the degraded gels were collected and 
stored. For the analysis of the stored samples, the protocol of the VEGF-A Human ELISA kit (BMS277-
2, ThermoFisher) was followed as described by the manufacturer. 
 
4.1.10. Cell culture 
 
Rat tenocytes were cultured in DMEM with low glucose (D6046, Sigma-Aldrich), containing 
10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Pen/Strep), and maintained at an 
atmosphere of 5% CO2, at 37 ºC. Medium was refreshed every 2 days. The cells were used when their 
confluency reached 80%-90% confluency. 
 
4.1.11. Formation of HCF hydrogels and cell seeding 
 
For the formation of HCF hydrogels, the previously described procedures were followed with 
the following conditions: 0%, 10%, 35% and 50% HCF; fibrinogen with non-conjugated heparin. 2D 
samples of cell suspension over coverslips were prepared in a 24-well microplate. 3D samples were 
prepared in a 96-well microplate, with the gels’ solutions being mixed with cell culture. The seeding for 
both 2D and 3D samples was aimed for 2500 cells/cm2. Cell culture medium was added to cover the 
gels. 
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4.1.12. Cell staining for fluorescence microscopy 
 
Samples were fixed with 4% PFA for 30 m at RT, rinsed thoroughly with PBS and left hydrated 
until further use. Permeabilization was done with 0.1% Triton X-100 in PBS for 30min at RT, followed 
by a thorough PBS rinsing. Samples were stained with a 1:100 dilution of Alexa Fluor 568 Phalloidin 
(A12380, Thermo-Fisher) for 1h at RT, and counterstained with DAPI (0.2 µg/ml, Thermo-Fisher) in 
PBS for 10m at RT. Afterwards, the samples were washed with PBS and visualized with a Live Cell 
Nikon TI-E microscope. 
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4.2. Results 
 
 
4.2.1. Nuclear Magnetic Resonance  
 
From the NMR analysis, chemical shifts correspondent to NHS-Heparin and fibrinogen were 
revealed in the Heparin-conjugated fibrinogen sample (Fig. 13). Heparin’s peaks (from approx. 2.5 to 
3.5 ppm) and Fibrinogen’s peaks (from approx. 1.75 to 2.5 ppm) are found in the modified fibrinogen 
NMR spectrum. 
 
 
 
Fig. 13. NMR spectra of pure fibrinogen, NHS-heparin (activated heparin) and modified (heparin-conjugated) fibrinogen. 
 
 
Tables 1 and 2 present the peaks of heparin and fibrinogen also identified in the modified 
fibrinogen NMR spectrum. 
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Table 1. Peaks in NMR spectra from pure fibrinogen and modified (heparin-conjugated) fibrinogen 
 
Fibrinogen [ppm] Modified Fibrinogen 
[ppm] 
2.6074 2.6262 
1.8474 1.8096 
  
 
 
Table 2. Peaks in NMR spectra from between NHS-heparin (activated heparin) and modified (heparin-conjugated) fibrinogen 
 
NHS-Heparin 
[ppm] 
Modified Fibrinogen 
[ppm] 
3.2653 3.223 
3.1631 3.163 
2.7872 2.7315 
0.9962 0.9993 
 
At least two peaks were found relevant (around the same ppm) and matched between the pure 
fibrinogen and the modified fibrinogen NMR spectra (Table 1). A higher number of matching peaks 
was found between the activated heparin and the modified fibrinogen NMR spectra. In this case, at least 
four matches were identified (Table 2). 
 
4.2.2. Fourier-transform infrared spectroscopy  
 
On the functional group region from the activated heparin spectrum, we can observe a N-H 
stretch around 3000 and 3400 cm-1. The presence of noise can be observed between 3400 cm-1 and 4000 
cm-1, and 1300 cm-1 and 1800 cm-1. Between 2300 cm-1 and 2400 cm-1, the presented peak has a pattern 
that might be mistaken for one of the most common types of spectral artifacts in FTIR spectra, which is 
carbon dioxide. There are no significant peaks between 800 cm-1 and 1400 cm-1. On the functional group 
region from the modified fibrinogen spectrum, we can observe an N-H stretch around 3000 and 3600 
cm-1. Again, the presence of noise can be observed between 1700 cm-1 and 2400 cm-1. 
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Fig. 14. FTIR transmission spectra of NHS-Heparin (activated heparin) (A), fibrinogen (B) and HCF (C). 
 
C 
A 
B 
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It is not possible to observe any similarity between the FTIR spectra of the activated heparin 
and the HCF. However, the results demonstrate that there is a close similarity in the FTIR spectra pattern 
between pure fibrinogen and HCF (Figs. 14 and 15). There is a high correlation of peaks between the 
two spectra. 
  
 
Fig. 15. FTIR transmission spectra of pure fibrinogen (in green), NHS-heparin (activated heparin) (in blue) and HCF (in red). 
 
With a thorough analysis of the peaks, in the functional group region, between 3500 and 3700 
cm-1, an alcohol (O-H) group was identified as a match between the activated heparin and the modified 
fibrinogen FTIR spectra. The matching range is represented in blue (Fig. 16). 
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Fig. 16. FTIR transmission spectra of NHS-heparin (activated heparin) (A), and modified fibrinogen (B) with an alcohol (O-
H) functional group range match (in blue). 
 
4.2.3. Gelation kinetics and staining of matrices with alcian blue 
 
For pure fibrinogen matrices, gelation took 15 minutes or less, while matrices with 40% and 
50% of HCF took approximately 45 minutes to form. Solutions with 75% of HCF concentration took at 
least 1h to gelate, whereas 100% HCF matrices showed no signs of gelation. 
 
Table 3. Gelation time of 0%, 40%, 50%, 75% and 100% modified (heparin-conjugated) fibrinogen matrices. 
 
 Gelation time 
Percentage of HCF 15 min 45 min >60 min 
    
0% 
 
  
40% 
 
 
 
50% 
 
 
 
75% 
  
 
100%  
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The alcian blue stained matrices demonstrate the occurrence of phase separation. This can be 
noticed as the concentration of HCF increases and the color becomes more intense and saturated (Fig. 
17 B, C and D). 
 
 
Fig. 17. Stained fibrinogen matrices with Alcian blue with 0% (A), 40% (B), 50% (C) and 75% (D) modified (heparin-
conjugated).  
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4.2.4. Heparin quantification with 1,9-Dimethyl-Methylene Blue 
 
The heparin quantification was performed to samples from three different conditions: (1) 
fibrinogen with non-conjugated heparin, (2) fibrinogen with conjugated heparin (before purification 
process), and (3) fibrinogen with conjugated heparin (after purification process). The DMMB assay’s 
(Fig. 18) shows that the highest heparin concentration was observed in the fibrinogen with non-
conjugated heparin sample, followed by the fibrinogen with conjugated heparin sample before the 
purification process. Fibrinogen with conjugated heparin after the purification process shows the lowest 
concentration of heparin. 
 
 
Fig. 18. Heparin concentration obtained from three different conditions: fibrinogen with non-conjugated heparin (Fib-Hep 
Free), fibrinogen with conjugated heparin (before purification process) and fibrinogen with conjugated heparin (after 
purification process). 
 
4.2.5. Heparin leaching test with 1,9-Dimethyl-Methylene Blue 
 
  
The heparin release from pure fibrin, HCF and fibrin with free heparin was quantified and 
compared over a 5-day period. As expected, pure fibrinogen samples showed an almost null and constant 
level at all timepoints. Fibrinogen with non-conjugated heparin showed a downward tendency, with 
about 4 μg/ml of heparin leached at day 1 and half of this value at day 2. A similar downward pattern 
was observed on 75% HCF sample, starting at day 1 with heparin leaching values between 6-8 μg/ml, 
reaching approximately 4 μg/ml at day 5. Lastly, regarding the 50% HCF sample, similar values of 
leached heparin were observed at day 1 and 5, between 4 and 5 μg/ml approximately, with a sudden 
peak at day 3 of about 7 μg/ml. 
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Fig. 19. Heparin leaching assay along days 1, 3 and 5 on four different conditions: pure fibrinogen, fibrinogen with non-
conjugated heparin, 50 % and 75% HCF matrices 
 
To evaluate the remaining concentration of heparin on the last day of the assay, the gels were 
degraded. Fibrinogen with non-conjugated heparin showed a lower heparin concentration in comparison 
to the 50% and 75% HCF samples (Fig. 20). In addition, the 75% HCF gels had a higher concentration 
of heparin in comparison to the 50% HCF gels. Pure fibrinogen gels presented residual values only. 
 
 
Fig. 20. Quantification of heparin retained in degraded gels (at day 5) on four different conditions: pure fibrinogen, 
fibrinogen with non-conjugated heparin, 50 % and 75% HCF matrices  
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4.2.6. VEGF-A release profile 
 
The VEGF-A release profile was performed with pure fibrinogen, fibrinogen with non-
conjugated heparin and HCF samples, with a duration of 7 days in static and non-static incubation 
conditions. 
 
In static conditions (Fig. 21), an upward movement was observed in all the samples. Pure 
fibrinogen and HCF samples presented a similar behavior until day 5, where pure fibrinogen’s release 
values began to rise. HCF matrices showed the lowest VEGF-A release value at day 7.  
 
 
Fig. 21. VEGF-A Release Profile without agitation (days 1, 3, 5 and 7) on three different conditions: pure fibrinogen, 
fibrinogen with non-conjugated heparin and HCF matrices 
 
 
For dynamic conditions (Fig. 22), all showed a stabilized behavior with VEGF-A released 
concentrations under 500 ng/ml, except fibrinogen with non-conjugated heparin matrices that showed a 
sudden increase of the VEGF-A release values up to approximately 200 ng/ml at the last day of the 
assay. 
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Fig. 22. VEGF-A Release Profile with agitation (days 1, 3, 5 and 7) on three different conditions: pure fibrinogen, fibrinogen 
with non-conjugated heparin and HCF matrices 
 
The results from the quantification of VEGF-A on gels degraded in day 10 show that pure fibrin 
hydrogels retain more VEGF-A in both with and without agitation conditions (Fig. 23). HCF matrices 
showed to retain less VEGF-A in both conditions at the last day of the assay. 
 
 
Fig. 23. VEGF-A retained in degraded gels with and without agitation (day 10) on three different conditions: pure fibrinogen, 
fibrinogen with non-conjugated heparin and HCF matrices 
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4.2.7. Cell attachment study 
 
The fluorescent images demonstrate the morphology of the cells on the different HCF’s 
concentrations matrices upon fixation (Fig. 24). In the Bright-field image, it is presented the control 
used to observe the morphology of live tenocytes in 2D (Fig. 24 A). 
 
 
Fig. 24. Fluorescent images of 3D hydrogel samples embedded with rat tenocytes and stained with Phalloidin (red), and 
counterstained nuclei with DAPI (blue): 0% (A), 10% (B), 35% (C), 50% modified (heparin-conjugated) fibrinogen hydrogel 
(D), and fibrinogen with non-conjugated heparin (E). The scalebar represents 100 µm. 
 
 
 
Fig. 25. Bright-field image of tenocytes cultured on 2D (day 1 of culture) (A) and fluorescent image of tenocytes stained with 
Phalloidin and DAPI (B). The scalebar represents 100 µm. 
 
 Tenocytes with a spread/elongated morphology were found in all HCF hydrogel samples. The 
imaging was performed in random regions of the samples. 
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4.3. Discussion 
 
NMR spectra analysis 
 
It should be noted that it was not mentioned, in the section 4.1.2, the first procedure created for 
the synthesis of Heparin-conjugated Fibrinogen (Appendix 1). The first procedure corresponds to a first 
attempt in the initial stage of the experimental activity to obtain the modified fibrinogen product, which 
was inspired by M. Kim et al. (2014) and H. Yang et al. (2010). Later on, the procedure was re-designed 
since the activation of heparin (12h) and reaction time with fibrinogen (3h) were found to be extensive 
and have a negative effect on the stability of reagents that are readily hydrolyzed. The steps were 
simplified, and the reaction’s concentrations, pH and temperature were adjusted. The first trial of 
synthesis of modified fibrinogen product was analyzed by NMR (Appendix 3). At first, the purpose was 
to recognize fibrinogen in the spectrum mainly by its characteristic sodium citrate peak. However, it 
was observed that this peak did not appear in the NMR spectra, probably due to the purification process 
involving dialysis. To check this hypothesis, a second NMR spectroscopic analysis was conducted with 
a non-dialyzed modified fibrinogen, which in fact presented the sodium citrate peak, highlighting the 
effect of dialysis in the elimination of this compound.  
 
As seen in Fig. 13, the chemical shifts of activated heparin were found to correlate with the ones 
presented by the HCF. In addition, it was also possible to identify matching peaks from heparin in the 
modified fibrinogen samples (Tables 1 and 2). A list of matching peaks between two or more substances 
was generated based on the ppm band range and the intensity of the signals. In that way, if two peaks or 
more peaks are found in a near ppm location and show similarities in signal intensity, the peaks are 
matched and retrieved. Chemical shifts correspondent to NHS-Heparin and fibrinogen were revealed in 
the HCF sample (Fig. 13). In a study based on the 1H-NMR spectra of 31 pure heparins, chemical shifts 
for peaks in heparin were always present at 5.42, 5.23, 5.01, 4.82, 4.60, 4.40, 4.34, 4.27, 4.12, 4.03, 
3.87, 3.77, 3.67, 3.40, 3.28, and 2.05 ppm. A correlation with the 1H-NMR HCF spectrum is found, 
where the relative intensities of the previously mentioned peaks vary, however, the chemical shifts differ 
only by <0.03 ppm (Z. Zhang et al., 2009). As expected, the N-acetyl protons of heparin show a single 
peak at 2.04 ppm (± 0.02ppm). A small dermatan sulfate peak, corresponding to N-acetyl protons of 
dermatan sulfate, shows near 2.08 ppm (The Federal Institute for Drugs and Medical Devices (BfArM), 
2017). With this, we can conclude that there was heparin in the product subjected to analysis. However, 
it is inconclusive if that heparin is free or is conjugated to fibrinogen. 
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FTIR spectra analysis 
 
For FTIR spectral reliability purposes, the spectra of sample and from the background were 
obtained at least twice. In this way, there were less chances of the presence of peaks not caused by the 
sample and, in general, due to FTIR spectral artifacts. Hence, the peak found with a similar pattern to 
carbon dioxide was not considered as so. 
FTIR spectra has two general regions (Fig. 14-16): the functional group region, which is 
between 1500 and 4000 cm-1; and the fingerprinting region, which is between 400 and 1500 cm-1. 
According to the results, the N-H stretch found in the spectrum of modified fibrinogen 
corresponds to the fibrinogen's N-H stretch. It was possible to relate the matching peaks revealed with 
NMR spectra with the peaks found in the FTIR spectrum, by conjugating the information of signal 
intensity and range of signal reveal. With this information, an alcohol (O-H) group from heparin was 
found in common with the modified fibrinogen, in a range between 3550-3700 cm-1 (Fig. 16). 
 
Gelation kinetics and alcian blue staining  
 
Regarding the gelation time, it was observed that it increases as the modified fibrinogen 
concentration in the hydrogels increases. In opposition, the lower the concentration of modified 
fibrinogen, the shorter was the time of gelation. 
Staining with alcian blue enabled a gross observation of heparin present within the hydrogels, 
since this dye forms salt linkages with the acid groups of sulfated glycosaminoglycans. Ideally, the 
hydrogels should be uniformly composed of modified fibrinogen, thus yielding a homogenous blue 
tonality throughout the whole sample. However, as the concentration of modified fibrinogen increased, 
the hydrogels’ staining color intensified and it was easier to observe phase separation; whereas the 
hydrogels formed with pure fibrinogen showed a consistent and uniform polymerization. Phase 
separation is a macroscopic phenomenon which is only observed when the size of the aggregates allows 
light scattering. Fibrinogen is a large molecule and its dimension might facilitate the observation of this 
phenomenon even in pure solution conditions (Fig. 17 A). In terms of modified fibrinogen gel conditions 
(Fig. 17 B, C and D), this behavior could be explained by the crosslinking of fibrinogen with heparin 
and increased dimensions of the molecular structure, as well as the non-addition of fibrin stabilizer 
factors such as factor XIII. 
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Heparin quantification 
 
With these results, we may conclude the presence of heparin in the HCF product, as well as the 
removal of non-conjugated heparin during dialysis. This last fact is confirmed due to HCF samples 
obtained after dialysis presenting the lowest concentration of heparin. 
 
Heparin leaching assay 
 
It was expected that pure fibrinogen samples would present zero heparin concentration. 
However, even though DMMB assay is widely accepted for its specific measurement of sulfated GAGs, 
due to fibrinogen’s properties and interaction with DMMB dye, residual values were detected. At day 
1, 50% and 75% HCF samples presented a non-expected behavior by showing higher values of leached 
heparin in comparison to non-conjugated gel samples. In addition, the highest amount of leached heparin 
at day 1 was presented by the 75% HCF gel samples. However, this fact might be justified by the 
possibility of the collected buffer from day 1 to contain non-retained heparin residues. Throughout the 
experiment, it is possible to observe a decrease of the amount of leached heparin by 75% HCF gels 
because of the recurrent buffer changes. On day 3 and day 5, the values of leached heparin decrease to 
similar values presented by 50% HCF samples. These results might be translated in signals of saturation 
at 50% HCF, i.e. gels formed with a percentage higher than 50% will not retain heparin. The same 
pattern is found in fibrinogen with non-conjugated heparin samples, with the highest value of heparin 
leaching during the assay’s time-period also being presented at day 1 and a consistent decrease behavior 
until day 5. For the 50% HCF gels, there is the appearance of a sudden peak at day 3. However, the 
pattern changes and begins to show the expected decreasing behavior. In addition, the quantification of 
retained heparin in degraded matrices at the last day of the assay was also performed, pointing out 75% 
HCF matrices as the ones retaining more heparin, in comparison to pure fibrinogen, 50% HCF and 
fibrinogen with non-conjugated heparin samples (Fig. 20). With these results, it is possible to confirm 
the attachment of heparin in HCF gels with a saturation level of 50%. 
 
VEGF-A release profile 
 
During a period of 7 days, modified fibrin matrices showed the lowest VEGF-A release in static 
conditions, in comparison to pure fibrinogen and fibrinogen with non-conjugated heparin matrices. In 
non-static conditions, the release of the growth factor remained constant and under 500 ng/ml. This 
concentration value is considered low and not significant since residual growth factor release from 
hydrogels is unavoidable. Hence, these results points to the ability of modified fibrin matrices in 
retaining VEGF-A. 
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Cell attachment in modified fibrin hydrogels 
 
The aim of this assay was to find out if the matrices formed with HCF were able to support cells 
attachment and spreading. According to Kalson et. al (2015), mouse tendon cells in 2D cell culture have 
a flat shape and a characteristic appearance of fibroblasts (Fig. 26). 
 
 
Fig. 26. Shape of isolated mouse tendon cell from E15.5 in 2D culture. The scalebar represents 10 µm. Adapted from (Kalson 
et al., 2015). 
 
2D samples with cell suspensions over coverslips were used as a control to determine the cells 
morphology and for further comparison purposes. It was observed that cells in a necrotic state presented 
a round shape, whereas live cells presented a spread elongated shape. In all the 3D HCF samples, cells 
with similar morphologies were found. However, conclusions about cell adhesion, spread and growth 
abilities in the different HCF gel conditions were not made because of the observed phase separation on 
the alcian blue stained gels, which could have compromised the cell seeded surface and environment. 
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Chapter 5: Fabrication of electrospun pNIPAM microfibers 
 
 
5.1. Materials and Methods 
 
 
5.1.1. Preparation of polymer solution 
 
The solutions for electrospinning were prepared by dissolving pNIPAM in a solvent mixture of 
chloroform and DMF with a volume ratio of 3:1 and 7:3, at a concentration of 40% and 50% (w/v), 
respectively. The solutions were mixed overnight with a stir bar and immediately used in the next day.  
 
5.1.2. Electrospun fibers formation and imaging 
 
The environmental conditions were kept constant with temperature at 23ºC and humidity at 
28%. The solutions were loaded into 5 mL plastic syringes and fed to the needle tip using a syringe 
pump. Positive voltages of 10, 20 and 25 kV were applied to the needle using a high voltage power 
supply. Respectively, the collector was placed at distances of 11.6, 10 and 13 cm from the needle tip. 
On applying high voltage, the polymer solution formed a Taylor cone at the needle tip and a positively 
charged jet was sprayed on a rotating mandrel collector at maximum speed. The electrospun fibers were 
collected on aluminum plates. The fibers were sputter-coated with gold, and their morphology was 
observed and recorded with a Nikon SMZ25 Stereomicroscope and a FEI/Philips XL30 Scanning 
Electron Microscope. 
 
5.2. Results 
 
All the electrospun fiber samples obtained from the different conditions presented a reasonable 
alignment and parallel pattern. This aspect was more notable in the 40% pNIPAM in a 7:3 
chloroform/DMF ratio sample, however, overlapping was observed and the bottom layer of the fibers 
was found weak (Fig. 27). 
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Fig. 27. Scanning electron microscopy image of a 40% pNIPAM electrospinning sample with 2.5 ml/h of flow rate, 10 kV of 
voltage and 11.6 cm of working distance (WD) in 7:3 Chloroform/DMF ratio. The scalebar represents 50 µm. 
 
    
Fig. 28. Scanning electron microscopy image of 50% pNIPAM electrospinning samples in 7:3 Chloroform/DMF ratio. Two 
images of a sample (A and B) with 2.5 ml/h of flow rate, 25 kV of voltage and 13 cm of working distance (WD). And, two 
images of a sample (C and D) with 2.5 ml/h of flow rate, 20 kV of voltage and 10 cm of WD. The scalebar represents 100 
(A), 20 (B), 50 (C) and 10 µm (D). 
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Fibers from 50% pNIPAM in a 7:3 chloroform/DMF ratio presented a flattened aspect which 
affected their cylindrical shape (Fig. 28). 
 
 
 
Fig. 29.  Scanning electron microscopy images of a 40% pNIPAM electrospinning sample in 3:1 Chloroform/DMF ratio. The 
scalebar represents 200 (A), 50 (B), 20 (C) and 10 µm (D). 
 
Similarly, some of the electrospun fibers from 40% pNIPAM in a 3:1 chloroform/DMF ratio 
sample also presented an irregular tubular morphology with some narrowed regions along the fibers 
(Fig. 29). 
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5.3. Discussion 
 
The fibers that most suited the desired properties -  tubular appearance, diameter between 5-20 µm 
(for resemblance of vessels’ diameter range in vivo) and a linear and parallel alignment (for cells 
orientation) - were found to be obtained from 40% pNIPAM in a 3:1 chloroform/DMF ratio. Even 
though some fibers did not seem to consistently present a cylindrical/tubular appearance over the sample 
surface (Fig. 29 A and B), and narrowed regions were found along some of the fibers, most of them did 
not present this aspect and were considered reasonable (Fig. 29 C and D). 
Electrospun fibers from 40% pNIPAM in a 7:3 chloroform/DMF ratio presented notable 
characteristics of alignment and parallel pattern but the overlapping and bottom layer weakness of the 
fibers were found to be a concern (Fig. 27). 
Finally, from 50% pNIPAM in a 7:3 chloroform/DMF ratio, in comparison to the other samples, the 
resulting fibers were found reasonable, even though a flattened aspect presented in the surface was 
observed (Fig. 28 B and D). 
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Chapter 6: Conclusion 
 
TE is a multidisciplinary area, thus in order to obtain functional products with quality, the 
cooperation between the various disciplines that comprise it must remain active and dynamic. An 
accurate understanding of biomaterials and cell biology with emphasis on cell differentiation, cell 
interaction and extracellular matrix formation is of great importance to succeed in tissue regeneration. 
It is also important to highlight the importance of dealing with and overcoming the emerging obstacles 
originated by the community related to cell seeding ethics. 
TE has a high market potential, hence investment in this area has grown in a gradual and 
sustained manner. Despite of this, the industry linked to the production of biomimetic 3D models still 
faces numerous challenges to improve the characteristics of the models and ensure the improvement of 
their performance. 
 
This thesis work can be divided into three main stages which involved:  
1. the process of optimizing and characterizing the hydrogel; 
2. seeding with tenocytes in order to test cell behaviors in the hydrogel, and 
3. fabricating pNIPAM microfibers for the hydrogel microchanneling. 
 
It was possible to optimize the production process of the hydrogel that resulted in the activation of 
heparin and its binding to fibrinogen, as observed through NMR and FTIR spectroscopic analysis. In 
relation to gelation time tracking, it was observed that as the HCF concentration increased, the time of 
gelation of the hydrogels increased as well. The staining of hydrogels with alcian blue pointed to some 
polymerization issues with 40%, 50% and 75% HCF. In spite of that, the hydrogels demonstrated the 
capacity to covalently attach heparin with a saturation limit of 50% HCF, and retain VEGF-A, as 
observed with hydrogels staining with dimethylmethylene blue and ELISA analysis. It was also 
successfully confirmed and identified the morphology of tenocytes in 3D HCF hydrogels. However, 
conclusions about adhesion, spreading and growth abilities in the different HCF gel conditions were 
made because of the observed phase separation on the alcian blue stained gels, which could have 
compromised the cell seeded surface and environment. Finally, it was observed that electrospun fibers 
obtained from 50% pNIPAM in a 7:3 chloroform/DMF ratio and 40% pNIPAM in a 3:1 
chloroform/DMF ratio enabled to obtain the desired fiber diameter (5-20 µm) and alignment (linear and 
parallel). 
 
In terms of limitations, a large amount of time was devoted to the analysis of NMR and FTIR spectra. 
The problem in NMR and IR spectroscopy is that the more complex the composition of a sample, the 
more difficult it becomes to understand what peaks correspond to functional groups, and to recognize 
its characteristic signals. Characterization assays of the HCF hydrogels were often delayed because not 
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enough HCF product was being obtained after each prepared batch - final amount of product obtained 
from the entire hydrogel fabrication process, since the first step of activation of heparin to the last step 
of freeze-drying. Several attempts were conducted in order to obtain proper electrospun fibers samples. 
These attempts regard the complexity of obtaining proper and consistent fibers without having already 
determined machine configurations and a “recipe” to prepare the polymer solution, in order to achieve 
the desired results. In specific, the most recurrent issue during the electrospinning procedure was the 
splitting of the Taylor Cone, which returned from none to just a few non-aligned fibers under the 
expected diameter range. Assays towards achieving microchanneling in the hydrogels were not 
performed because a reasonable amount of results regarding the optimized properties of the hydrogel 
were expected before the embedding of the fibers. 
 
In terms of future perspectives, it is suggested a continued optimization of the HCF hydrogels' 
formation process in order to improve the acquisition of a consistent HCF product in larger amounts, 
consequently avoiding the need of constant batch preparation and delay of important and further 
investigation assays. In addition, the formation of HCF hydrogels should be studied in variations of 
solution pH, temperature, fibrinogen and thrombin concentrations, addition of stabilizers and anti-
degradation factors, in order to minimize polymerization difficulties. These might have been caused by 
the fibrinogen concentration (as shown by the results, pure fibrinogen concentration has a high influence 
in the gelation and polymerization process), the thrombin and calcium chloride concentrations (whose 
unreasonable mixed ratios may result in a less stable fibrin gel), and/or the non-addition of crosslinkers 
to matrix formula (factor XIII and others are usually used in gel formation because of their positive 
effect and enhancement of the formation of a homogeneous and complex polymerized network), among 
others. It is also suggested a better characterization of the hydrogels, especially in situations of cells 
incorporation, to determine with certainty the effect of the fabricated 3D environment in cell behavior. 
In the future, it is intended to achieve a better usage of the 3D biomimetic models’ potential for the 
repair and regeneration of tissues, as well as the understanding and cure of pathologies; as in specific, 
the results obtained are expected to contribute to the development of neuronal and vascular biomimetic 
models, either singular or combined, for in vitro studies and regenerative applications. 
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Appendices 
 
Appendix 1 
 
This text corresponds to the first method designed to obtain Heparin-conjugated Fibrinogen.  
 
30 mg of Heparin were dissolved in a 2-(N-morpholino)ethanesulfonic acid buffer solution 
(MES, 0.5M, pH 6). N-hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride (EDC) were added to the previous solution to have a final concentration of 
0.04 mM and 0.08 mM. The solution was left to react for 12 h at 4ºC under agitation for activation of 
the Heparin’s carboxylic acid groups. It was then stirred to obtain a homogeneous solution and 
precipitated to extract the activated Heparin using excess of acetone anhydride, followed by vacuum dry 
for 24 h at 20°C. 30 mg were dissolved in 6 ml of warm (at 37ºC) PBS of Fibrinogen. 18 mg of activated 
Heparin product were added and reacted for 3 h at 4ºC under agitation. The resultant solution was 
precipitated using excess of acetone anhydride and vacuum dried for 24 h at 20ºC. The dried product 
was dissolved in Phosphate Buffered Saline (PBS), dialyzed through a porous membrane bag for 24 h 
at 4ºC (with MilliQ water changes every 2-4 h), and lyophilized for 48 h. 
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Appendix 2 
 
This appendix has the purpose of describing how the carbodiimide chemistry works and 
important crosslinking remarks related to this thesis work. 
 
Crosslinking: it is the process of chemically joining two or more molecules by a covalent bond. 
Functional groups (primary amines, etc.) on proteins or other molecules are found to be reactive with 
specific crosslinking reagents ends. Chemical groups become targets for conjugation and for study using 
crosslinking methods because of their availability in proteins and peptides. This area of chemistry is 
known as bioconjugation and includes not only crosslinking processes, but also immobilization 
procedures, surface modifications and labeling of biomolecules. 
 
The reactive chemical group: the most important property of a crosslinker is its reactive 
chemical group, since it establishes the method and mechanism for chemical modification. At least two 
reactive groups are found in crosslinkers and, as previously mentioned, these target common functional 
groups found in biomolecules such as proteins and nucleic acids. The functional groups that are 
commonly targeted for bioconjugation include primary amines, carbohydrates, sulfhydryls, carbonyls 
and carboxylic acids. 
 
Carboxylic acid-reactive chemical groups: carboxylic acids (–COOH) exist in the side chains 
of aspartic acid (Asp, D) and glutamic acid (Glu, E), and at the C-terminus of each polypeptide chain. 
Carboxylic acids are reactive towards carbodiimides. 
 
Carbodiimides: EDC and other carbodiimides cause direct conjugation of carboxylates (–
COOH) to primary amines (–NH2) without becoming part of the final amide-bond crosslink between 
target molecules. Direct EDC-mediated crosslinking usually causes random polymerization of 
polypeptides because peptides and proteins contain multiple carboxyls and amines. Nevertheless, this 
reaction is widely used in immunogen preparation (e.g., attaching a large carrier protein to a small 
peptide), and in immobilization procedures (e.g., attaching proteins to a carboxylated surface). 
 
EDC reaction: an active O-acylisourea intermediate is formed by the reaction of EDC with 
carboxylic acid groups. This intermediate is easily displaced by nucleophilic attack from primary amino 
groups in the reaction mixture. The original carboxyl group forms an amide bond with the primary 
amine, and an EDC by-product is released as a soluble urea derivative. In aqueous solutions, the O-
acylisourea intermediate is unstable, and if the reaction with an amine fails, it will result in the 
regeneration of the carboxyls, the hydrolysis of the intermediate, and the release of an N-unsubstituted 
 58 
 
urea. EDC crosslinking is most efficient and must be performed in acidic (pH 4.5) buffer conditions 
with no extra possession of carboxyls and amines. A suitable carbodiimide reaction buffer is MES (4-
morpholinoethanesulfonic acid). In addition, phosphate buffers and neutral pH (up to 7.2) conditions 
are also compatible with the reaction chemistry, but present lower efficiency values. However, 
increasing the amount of EDC in a reaction solution can compensate for the reduced efficiency (Thermo 
Fisher Scientific Inc., 2012). 
 
EDC and Sulfo-NHS reaction: N-hydroxysuccinimide (NHS) or its water-soluble analog (sulfo-
NHS) are often included in EDC coupling procedures to create dry-stable (amine-reactive) intermediates 
or to improve efficiency process efficiency (Fig. 30).  
 
 
Fig. 30. Sulfo-NHS plus EDC (carbodiimide) crosslinking reaction scheme: carboxyl-toamine crosslinking using the 
carbodiimide EDC and Sulfo-NHS. Addition of NHS or Sulfo-NHS to EDC reactions increases efficiency and enables 
specific molecule (1) to be activated. From (Thermo Fisher Scientific Inc., 2012). 
 
In comparison to normal EDC reaction, EDC with NHS form a coupling with carboxyls, 
presenting an NHS ester that is considerably more stable than the O-acylisourea intermediate, while 
allowing efficient conjugation to primary amines at physiologic pH. 
 
Activation of heparin: according to literature, EDC/NHS can activate carboxyl acid groups of 
the heparin and promote their covalent binding to amino groups; which has been proved to be non-
cytotoxic (You, Kang, Byun, & Lee, 2011) and biocompatible (Elahi, Guan, Wang, & King, 2014; W.-
C. Lin, Liu, & Yang, 2004). 
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Appendix 3 
 
This appendix has the purpose of describing how the Nuclear Magnetic Resonance (NMR) 
works and important remarks related to this thesis work. 
 
The NMR spectroscopy is an analytical chemistry technique used for determining the content, 
molecular structure and purity of a sample (Institute of Chemistry, The Hebrew University of Jerusalem, 
2017). Mixtures containing known compounds can be quantitatively analyzed by NMR. For unknown 
compounds, NMR can also analyze them by finding matches against spectral libraries or to infer the 
basic structure directly. Once the basic structure is known, the molecular conformation in solution can 
also be determined by NMR as well as studying physical properties at the molecular level, such as phase 
changes, solubility, diffusion, among others. 
 
The principle of NMR is that many nuclei have spin and all nuclei are electrically charged.  An 
energy transfer is possible between the base energy to a higher energy level (generally a single energy 
gap) if an external magnetic field is applied. The energy transfer takes place at a wavelength that 
corresponds to radio frequencies, and the energy is emitted at the same frequency once the spin returns 
to its base level. The signal that matches this transfer is measured in many ways and processed in order 
to yield an NMR spectrum for the nucleus in concern (McGraw-Hill Higher Education, 2000). 
 
 
Fig. 31. Schematic of NMR spectrometer sample handling and spectrum output. From (McGraw-Hill Higher Education, 
2000). 
The sample is positioned in the magnetic field and excited via pulsations in the radio frequency 
input circuit. A radio signal in the output circuit is induced by the realigned magnetic fields, and it is 
used to generate the output signal. Fourier analysis of the complex output produces the actual spectrum. 
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To allow the signals to be identified from the background noise, the pulse is repeated as many times as 
necessary (McGraw-Hill Higher Education, 2000). 
 
The chemical shift 
 
 An NMR spectrum is a plot of the radio frequency applied against absorption. 
 Resonance is the signal in the spectrum. 
 The frequency of a signal is referred to as a chemical shift. 
 
In absolute terms, the chemical shift is defined by the frequency of the resonance expressed with 
reference to a standard compound which is defined to be at 0 ppm. 
 
𝐶ℎ𝑒𝑚𝑖𝑐𝑎𝑙 𝑠ℎ𝑖𝑓𝑡 (𝛿) =
𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑠𝑖𝑔𝑛𝑎𝑙 − 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒
𝑠𝑝𝑒𝑐𝑡𝑟𝑜𝑚𝑒𝑡𝑒𝑟 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦
× 106 
 
Equation 1. Chemical shift of NMR 
 
By expressing it in parts per million (ppm), the scale is made more manageable and is 
independent of the spectrometer frequency. In this way, it is more convenient to describe the relative 
positions of the resonances in an NMR spectrum. The following chemical shift sheet was used in order 
to analyze the NMR spectrum (Fig. 32). 
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Fig. 32. NMR Chemical Shifts sheet. From (Starkey, 2017). 
 
  
 62 
 
Appendix 4 
 
This appendix has the purpose of describing how the Fourier-transform infrared spectroscopy 
(FTIR) works and important remarks related to this thesis work. 
 
FTIR is an infrared spectroscopy method where some IR radiation is passed through a sample 
and absorbed, and/or transmitted (Thermo Fisher Scientific Inc., 2017a). The resulting signal at the 
detector is a spectrum representing a molecular "fingerprint" of the sample. This is useful since different 
chemical structures (molecules) produce different spectral fingerprints. Hence, structural insights from 
the samples can be obtained. 
 
 
Fig. 33. Schematic of FTIR spectrometer. From (Baker et al., 2014). 
 
There are four major IR-spectroscopic sampling techniques: transmission, specular reflection, 
diffuse reflectance and attenuated total reflection (ATR). In this thesis work, the samples were solid, 
and hence, this was the ideal technique since the samples could be analyzed with a diamond ATR-crystal 
which possessed extreme chemical and mechanical robustness. The technique worked well for these 
samples because the intensity of the evanescent waves decays exponentially with distance from the 
surface of the ATR crystal, making the technique generally insensitive to the solid samples’ thickness. 
When the beam comes into contact with a sample, the ATR accessory operates by measuring the changes 
that occur in an internally reflected IR beam (Fig. 34). 
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Fig. 34. ATR principle. From (Bruker Optics, 2012). 
 
The infrared beam will enter the ATR crystal at an angle, relative to the crystal surface, of 
typically 45° and will be totally reflected at the crystal to sample interface. The fraction of light reaching 
into the sample is known as evanescent wave. Its penetration depth depends on the wavelength, the 
refractive indices of the ATR crystal, the sample and the angle of the entering light beam. The evanescent 
wave will be attenuated in the spectral regions where the sample absorbs energy. The attenuated beam 
will return to the crystal, then exits the opposite end of the crystal and be directed to the detector in the 
IR spectrometer. The detector will record the received IR beam as a signal, which will be used to 
generate the IR spectrum (Thermo Fisher Scientific Inc., 2017b). 
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Appendix 5 
 
This appendix has the purpose of describing how the Scanning Electron Microscopy (SEM) 
works and important remarks related to this thesis work. 
 
Many structures can no longer be characterized by light microscopy, since nowadays, for several 
reasons, materials and devices are shrinking and going towards smaller dimensions. The electron 
microscope was developed when the wavelength became the limiting factor in light microscopes. 
Electrons enable better resolutions since they have much shorter wavelengths (Nanoscience Instruments, 
2017). 
 
 
Fig. 35. Schematic of a scanning electron microscope. From (National Programme on Technology Enhanced Learning, 
2017). 
 
SEM uses an electron gun that generates a beam of high energy electrons, processed by magnetic 
lenses, focused at the specimen surface and systematically scanned (“rastered”) across the surface of a 
specimen. The electrons in a scanning electron microscope never form a real image of the sample, unlike 
the light in a light microscope. The SEM image is an electronic image, it is in the form of a serial data 
stream. This is the result of the beam probe illuminating the sample in a rectangular scanning pattern 
(raster) one point at a time, with the strength of the signal generated from each point being a reflection 
of differences (e.g. topographical or compositional) in the sample (Australian Microscopy and 
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Microanalysis Research Facility, 2013). In a one-to-one relationship between points on the specimen 
and points on the image viewing screen, the screen is scanned in synchrony with the beam on the 
specimen. Increased magnification is produced by decreasing the size of the scanned area (Australian 
Microscopy and Microanalysis Research Facility, 2013). 
 
Sputter coating 
 
Sputter coating for SEM is the process of applying an ultra-thin coating of electrically-
conducting metal over poorly or non-conducting conducting specimen. Examples of the metal could be 
gold (Au), gold/palladium (Au/Pd), silver (Ag), chromium (Cr), iridium (Ir) or platinum (Pt) (Höflinger, 
2013). Sputtered films for SEM typically have a thickness range of 2–20 nm. Because of the 
accumulation of static electric fields, charging of the specimen could occur. To prevent this, the sputter 
coating process should be performed. The signal to noise ratio can also be increased with SEM by 
increasing the number of secondary electrons that can be detected from the surface of the specimen. 
 
In general, the general advantages for SEM samples that are sputtered with metal are: 
 
 Increasing of thermal conduction; 
 Improvement of secondary electron emission; 
 Reduction of microscope beam damage; 
 Reduction of sample charging (increased conduction); 
 Reduction of beam penetration with improved edge resolution, and 
 Protection of beam sensitive specimens (Höflinger, 2013). 
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Appendix 6 
 
This appendix has the purpose of describing how the ELISA (enzyme-linked immunosorbent) 
assay works and important remarks related to this thesis work. 
 
ELISA (enzyme-linked immunosorbent assay) is a plate-based assay technique that detects and 
quantifies substances such as antibodies, proteins, peptides and hormones. The principle of ELISA is 
that an antigen must be immobilized to a solid surface, and complexed with an antibody that is linked 
to an enzyme. The detection consists in assessing the conjugated enzyme activity through the incubation 
with a substrate to produce a measurable product. The most crucial characteristic of the detection step 
is a highly specific antibody-antigen interaction (Thermo Fisher Scientific Inc., 2017c). Generally, the 
assay begins with a coating step, where the first layer, either an antigen or an antibody, is adsorbed to a 
well in an ELISA plate. Coating is followed by blocking and detection steps. Several washes are repeated 
between each ELISA step to remove unbound materials, since the assay uses surface binding for 
separation.  During this process, to prevent the dilution of the solutions added in the next phase, the 
removal of excess liquid is essential (Bio-Rad, 2017a). 
 
In general, ELISAs can be grouped into four main categories: direct, indirect, sandwich, and 
competitive ELISAs. In this thesis work, the sandwich ELISA procedure was used. The advantages of 
a sandwich ELISA are its high sensitivity, and delivery of high specificity as two antibodies are used to 
detect the antigen. It offers flexibility since both direct and indirect methods can be used. Sandwich 
ELISAs require the use of matched antibody pairs composed by the capture and the detection antibodies. 
Therefore, each antibody is specific for a different and non-overlapping region or epitope of the antigen. 
Matched antibody pairs should be tested specifically in sandwich ELISA to ensure that they detect 
different epitopes. This is very important in order to achieve accurate results. The capture antibody, as 
its name implies, will bind the antigen to later be detected in a direct or in an indirect ELISA 
configuration (Bio-Rad, 2017). 
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Fig. 36. Overview of a sandwich ELISA.  From (Rockland Immunochemicals, 2017). 
 
The sandwich ELISA process begins with a well of the ELISA plate to be coated with a capture 
antibody (Fig. 36). The sample is then added, followed by a detection antibody. If the detection antibody 
can be enzyme conjugated, then this is referred to as a direct sandwich ELISA. Indirect sandwich ELISA 
is when a secondary enzyme-conjugated detection antibody is required because the detection antibody 
used is unlabeled. Since the antigen does not need to be purified prior to the assay and it still delivers 
high sensitivity and specificity, sandwich ELISAs seem to be more suited to the analysis of complex 
samples (Bio-Rad, 2017). 
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Appendix 7 
 
This appendix has the purpose of describing how the used staining methods (alcian blue, 
DMMB, phalloidin and DAPI) work and important remarks related to this thesis. 
 
Alcian blue is a group of polyvalent basic dyes that are water soluble and it was used for 
heparin’s detection because it is a known staining assay of acidic GAGs that are carboxylated or sulfated. 
It stains both sulfated and carboxylated acid glycosaminoglycans and sulfated and carboxylated 
glycoproteins (LEV & SPICER, 1964; Scott & Dorling, 1965). The blue color is due to the presence of 
copper in the molecule. The staining reaction happens because Alcian blue forms salt linkages with the 
acid groups of acid mucopolysaccharides. 
The dye 1,9-dimethylmethylene (DMMB) is a thiazine chromotrope agent that presents a 
change in the absorption spectrum due to the resulting color of the stain becoming different from the 
color of the dye solution when bound to sulfated GAGs. This fact enables the detection of GAGs in 
solution (Whitley et al., 1989; Chandrasekhar et al., 1987; Farndale et al., 1982), and that is why this 
method is widely known and used for GAGs staining. 
Phalloidin is a bicyclic peptide that is made from a deadly mushroom named "Death Cap" 
(Amanita phalloides). It has a high-affinity for F-actin, a linear polymer microfilament found in almost 
all eukaryotic cells, driving many cellular processes including cell motility and muscle contraction. 
Phalloidin binds to actin at the junction between subunits (Barden et al., 1987; Faulstich et al., 1993; 
Steinmetz et al., 1998). It is a convenient probe for labeling, identifying, quantitating, and stabilizing F-
actin in fixed and permeabilized cell cultures, tissue sections or cell-free experiments. 
Finally, 4',6-diamidino-2-phenylindole (DAPI) is a popular nuclear and chromosome 
counterstain which forms fluorescent complexes with natural double-stranded DNA, showing a 
fluorescence specificity for AT, AU and IC clusters. When bound to double-stranded DNA, DAPI has 
an absorption maximum at a wavelength of 358 nm (ultraviolet) and its emission maximum is at 461 
nm (blue). Therefore, for fluorescence microscopy DAPI is excited with ultraviolet light and is detected 
through a blue/cyan filter. 
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